The low affinity PCP sites in the rat cerebellum not only bind TCP-like but also BTCP-like structures

European Journal of Medicinal Chemistry

Volumn 35, Issue 3, 2000, Pages 323-331

  Espaze, Florence ^a   Hamon, Jacques ^a   Hirbec, Hélène ^b   Vignon, Jacques ^b   Kamenka, Jean Marc ^a  

^a Centre National de la Recherche Scientifique   (France)

^b INSERM   (France)

Author keywords

BTCP; BTCP analogues; DA transporter; PCP receptor subsites; Rat cerebellum; TCP; TCP analogues

Indexed keywords

1 [1 (2 BENZO[B]THIENYL)CYCLOHEXYL]PIPERIDINE; DOPAMINE; DOPAMINE TRANSPORTER; DOPAMINE UPTAKE INHIBITOR; PHENCYCLIDINE; PHENCYCLIDINE DERIVATIVE;

ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CEREBELLUM; CHEMICAL MODIFICATION; DOPAMINE UPTAKE; DRUG BINDING SITE; DRUG SELECTIVITY; DRUG STRUCTURE; FOREBRAIN; NONHUMAN; RAT;

EID: 0034126282     PISSN: 02235234     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0223-5234(00)00135-5     Document Type: Article

References (27)

1. Vignon J., Pinet V., Cerruti C., Kamenka J.M., Chicheportiche R. Eur. J. Pharmacol. 148:1988;427-436.
2. Ilagouma A.T., Maurice T., Duterte-Boucher D., Coderc E., Vignon J., Costentin J., Kamenka J.M. Eur. J. Med. Chem. 28:1993;377-385.
3. Cerruti C., Drian M.J., Kamenka J.M., Privat A. Brain Res. 55:1991;51-57.
4. Maurice T., Vignon J., Kamenka J.M., Chicheportiche R. J. Neurochem. 56:1991;553-559.
5. Martin-Fardon R., Arnaud M., Rousseau E., Kamenka J.M., Privat A., Vignon J. Neurosci. Lett. 211:1996;179-182.
6. Koek W., Colpaert F.C., Woods J.H., Kamenka J.M. J. Pharmacol. Exp. Ther. 250:1989;1019-1027.
7. Duterte-Boucher D., Kamenka J.M., Costentin J. Psychopharmacology. 101:1990;344-353.
8. French E.D., Lopez M., Peper S., Kamenka J.M., Roberts D.C.S. Behav. Pharmacol. 6:1995;223-228.
9. Prinssen E.P.M., Kleven M.S., Vignon J., Kamenka J.M., Koek W. J. Pharmacol. Exp. Ther. 276:1996;904-911.
10. Loustau-Then I., Ponchant M., Fuseau C., Kamenka J.M., Vignon J., Crouzel C. Nucl. Med. Biol. 24:1997;513-518.
11. Hamon J., Espaze F., Vignon J., Kamenka J.M. Eur. J. Med. Chem. 34:1999;125-135.
12. Bruylants P. Bull. Soc. Chim. Belg. 33:1924;467-478. and 35 (1926) 139-154.
13. Geneste P., Kamenka J.M., Dessapt P. Bull. Soc. Chim. Fr. 3 et 4 II:1980;186-191.
14. Minato A., Tarrao K., Hayashi T., Susuki K., Kumada M. Tetrahedron Lett. 52:1981;5319-5322.
15. Winberg H.E., Fawcett F.S., Mochel W.E., Theobald C.W. J. Am. Chem. Soc. 82:1960;1428-1435.
16. Rice K.C., Dyer J.R. J. Heterocycl. Chem. 12:1975;1325-1326.
17. Mann J., Holland H. Tetrahedron. 43:1987;2533-2542.
18. Mohamadi F., Spees M., Grindey J. J. Med. Chem. 35:1992;3012-3016.
19. Yoshironi T., Milton L., Raymond N. J. Heterocycl. Chem. 18:1981;967-972.
20. Rabjohn N. Organic Synthesis. Vol. IV:1963;628 Wiley, London.
21. Geneste P., Kamenka J.M. Org. Magn. Res. 7:1975;579-584.
22. Manoharan M., Eliel E.L., Kanan W. Tetrahedron Lett. 25:1984;3267-3268.
23. Vignon J., Privat A., Chaudieu I., Thierry A., Kamenka J.M., Chicheportiche R. Brain Res. 378:1986;133-141.
24. Ebert B., Wong E.H.F., Krogsgaard-Larsen P. Eur. J. Pharmacol. 208:1991;49-52.
25. Berman F.W., Murray T.F. J. Biochem. Toxicol. 11:1996;217-226.
26. Hamon J., Vignon J., Kamenka J.M. Eur. J. Med. Chem. 31:1996;489-495.
27. Eiden F., Schmidt M., Buchborn H. Arch. Pharmacol. 320:1987;348-361.